Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients
Condition: Duchenne Muscular Dystrophy Intervention: Drug: AVI-4658 (Eteplirsen) Sponsor: AVI BioPharma, Inc. Active, not recruiting - verified August 2011